CTCX
Price
$0.23
Change
-$0.00 (-0.00%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
7.08M
PRQR
Price
$2.13
Change
-$0.20 (-8.58%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
246.76M
Earnings call today
Ad is loading...

CTCX vs PRQR

Header iconCTCX vs PRQR Comparison
Open Charts CTCX vs PRQRBanner chart's image
Carmell
Price$0.23
Change-$0.00 (-0.00%)
Volume$400
Capitalization7.08M
ProQR Therapeutics
Price$2.13
Change-$0.20 (-8.58%)
Volume$791
Capitalization246.76M
CTCX vs PRQR Comparison Chart
Loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTCX vs. PRQR commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTCX is a Hold and PRQR is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (CTCX: $0.23 vs. PRQR: $2.33)
Brand notoriety: CTCX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTCX: 3% vs. PRQR: 106%
Market capitalization -- CTCX: $7.08M vs. PRQR: $246.76M
CTCX [@Biotechnology] is valued at $7.08M. PRQR’s [@Biotechnology] market capitalization is $246.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTCX’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • CTCX’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTCX and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTCX’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • CTCX’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than CTCX.

Price Growth

CTCX (@Biotechnology) experienced а -2.08% price change this week, while PRQR (@Biotechnology) price change was -8.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -9.54%, and the average quarterly price growth was -4.71%.

Reported Earning Dates

CTCX is expected to report earnings on Mar 17, 2023.

PRQR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($247M) has a higher market cap than CTCX($7.08M). PRQR YTD gains are higher at: -12.075 vs. CTCX (-15.801). CTCX has higher annual earnings (EBITDA): -9.47M vs. PRQR (-18.59M). PRQR has more cash in the bank: 89.4M vs. CTCX (1.14M). CTCX has less debt than PRQR: CTCX (782K) vs PRQR (17.4M). PRQR has higher revenues than CTCX: PRQR (17.9M) vs CTCX (32.8K).
CTCXPRQRCTCX / PRQR
Capitalization7.08M247M3%
EBITDA-9.47M-18.59M51%
Gain YTD-15.801-12.075131%
P/E Ratio0.49N/A-
Revenue32.8K17.9M0%
Total Cash1.14M89.4M1%
Total Debt782K17.4M4%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTCXPRQR
RSI
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
39%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
39%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 26 days ago
51%
Bullish Trend 13 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
CTCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCGIX32.930.57
+1.76%
Goldman Sachs Large Cap Gr Insghts Instl
JBAWX29.210.29
+1.00%
JHancock Balanced R6
ASEFX14.920.12
+0.81%
Nuveen Small Cap Select R6
PNGYX14.300.08
+0.56%
Putnam International Value Y
GAGEX22.320.11
+0.50%
Guinness Atkinson Global Energy

CTCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTCX has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CTCX jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
-2.08%
RAIN - CTCX
53%
Loosely correlated
-9.75%
ATNF - CTCX
37%
Loosely correlated
N/A
PASG - CTCX
29%
Poorly correlated
+1.59%
PRQR - CTCX
28%
Poorly correlated
-0.43%
SNPX - CTCX
27%
Poorly correlated
-3.23%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-0.43%
KRRO - PRQR
58%
Loosely correlated
+1.37%
WVE - PRQR
53%
Loosely correlated
+0.09%
ATNF - PRQR
53%
Loosely correlated
N/A
ENVB - PRQR
43%
Loosely correlated
+32.08%
LOGC - PRQR
32%
Poorly correlated
-4.88%
More